Advertisement

Topics

Vivus, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

01:29 EDT 29 Jul 2018 | BioPortfolio Reports

Vivus, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Vivus, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Vivus, Inc. Vivus or 'the company' is a biopharmaceutical company focused on research, development and commercialization of products in the areas of obesity, sleep apnea, diabetes, and sexual health. The company primarily operates in the US. Vivus is headquartered in Mountain View, California, and employed 82 people as of February 29, 2016.


Scope


Detailed information on Vivus, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Vivus, Inc. in the form of a SWOT analysis

An indepth view of the business model of Vivus, Inc. including a breakdown and examination of key business segments

Intelligence on Vivus, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Vivus, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Vivus, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Vivus, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Vivus, Inc.'s business structure, strategy and prospects.

Original Article: Vivus, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Vivus, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...